{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:29:07Z","timestamp":1787027347336,"version":"build-2736575974"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Canine mesotheliomas are uncommon malignant tumors typically detected late. Minimally invasive diagnostic biomarkers would facilitate diagnosis at earlier stages, thereby improving clinical outcomes. We hypothesized that mesothelin could be used as a reliable diagnostic biomarker for canine mesotheliomas since it has been used as a cancer biomarker for human mesothelioma. We aimed to explore and characterize mesothelin gene expression in dogs and assess its use as a diagnostic biomarker for canine mesotheliomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We quantified expressed canine mesothelin transcripts via reverse transcription polymerase chain reaction (RT-PCR) and sequenced them using ribonucleic acid (RNA) extracted from a canine mesothelioma cell line. After confirming mesothelin expression, we assessed its levels in major organ tissues and compared them with those in the mesothelioma tissues using quantitative PCR (qPCR). Mesothelin overexpression in mesotheliomas was detected, and we further compared its levels using qPCR between mesotheliomas and non-mesotheliomas using tumor tissues and clinical sample effusions, confirming its significance as a diagnostic biomarker for canine mesothelioma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Mesothelin complementary deoxyribonucleic acid (cDNA) was amplified via RT-PCR, yielding a single band of expected upon DNA electrophoresis. Sequence analyses confirmed it as a predicted canine mesothelin transcript from the genome sequence database. Comparative sequence analysis of the deduced amino acid sequence of the expressed canine mesothelin demonstrated molecular signature similarities with the human mesothelin. However, the pre-sequence of canine mesothelin lacks the mature megakaryocyte potentiating factor (MPF) portion, which is typically cleaved post-translationally with furin. Mesothelin expression was quantified via qPCR revealing low levels in the mesothelial and lung tissues, with negligible expression in the other major organs. Canine mesothelin exhibited significantly higher expression in the canine mesotheliomas than in the noncancerous tissues. Moreover, analysis of clinical samples using qPCR demonstrated markedly elevated mesothelin expression in canine mesotheliomas compared to non-mesothelioma cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion and conclusion<\/jats:title>\n                    <jats:p>Canine mesothelin exhibits molecular and biological characteristics akin to human mesothelin. It could serve as a vital biomarker for diagnosing canine mesotheliomas, applicable to both tissue- and effusion-based samples.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fvets.2024.1436621","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T01:11:08Z","timestamp":1725844268000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Characterization of mesothelin gene expression in dogs and overexpression in canine mesotheliomas"],"prefix":"10.3389","volume":"11","author":[{"given":"Rina","family":"Nabeta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Kanaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aritada","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Oyamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daigo","family":"Azakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Uchide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1177\/030098588001700412","article-title":"Pericardial mesothelioma with cardiac tamponade in a dog","volume":"17","author":"Ikede","year":"1980","journal-title":"Vet Pathol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1292\/jvms.17-0631","article-title":"Thoracoscopic pericardiectomy associated with fully implantable catheter via thoracoscopy in the management of mesothelioma in a bitch","volume":"81","author":"HARTMANN","year":"2019","journal-title":"J Vet Med Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/vco.12777","article-title":"Clinical presentation, treatment and outcome of canine malignant mesothelioma: a retrospective study of 34 cases","volume":"20","author":"Moberg","year":"2022","journal-title":"Vet Comp Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/vcp.13002","article-title":"Comparison of effusion cell block and biopsy immunohistochemistry in mesothelial hyperplasia, mesothelioma, and carcinoma in dogs","volume":"50","author":"Milne","year":"2021","journal-title":"Vet Clin Pathol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1177\/030098589202900312","article-title":"Canine pericardial mesothelioma","volume":"29","author":"McDonough","year":"1992","journal-title":"Vet Pathol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.2460\/javma.235.12.1456","article-title":"Echocardiographic and clinicopathologic characterization of pericardial effusion in dogs: 107 cases (1985\u20132006)","volume":"235","author":"MacDonald","year":"2009","journal-title":"J Am Vet Med Assoc"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/vco.12843","article-title":"Outcome of dogs treated with chemotherapy for mesothelioma: a retrospective clinical study on 40 cases and a literature review","volume":"20","author":"Lajoinie","year":"2022","journal-title":"Vet Comp Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers","volume":"93","author":"Chang","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1373\/clinchem.2006.079327","article-title":"MESOMARK: a potential test for malignant pleural mesothelioma","volume":"53","author":"Beyer","year":"2007","journal-title":"Clin Chem"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1158\/0008-5472.CAN-14-0337","article-title":"Discovery of mesothelin and exploiting it as a target for immunotherapy","volume":"74","author":"Pastan","year":"2014","journal-title":"Cancer Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.3390\/cancers13163932","article-title":"Hitting the bull\u2019s-eye: Mesothelin\u2019s role as a biomarker and therapeutic target for malignant pleural mesothelioma","volume":"13","author":"Yeo","year":"2021","journal-title":"Cancers"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/biomedicines9040397","article-title":"Mesothelin expression in human tumors: a tissue microarray study on 12,679 tumors","volume":"9","author":"Weidemann","year":"2021","journal-title":"Biomedicines"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1097\/00000478-200311000-00003","article-title":"Application of mesothelin immunostaining in tumor diagnosis","volume":"27","author":"Ord\u00f3\u00f1ez","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/s0046-8177(03)00177-1","article-title":"Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas","volume":"34","author":"Frierson","year":"2003","journal-title":"Hum Pathol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"26744","DOI":"10.18632\/oncotarget.15814","article-title":"Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma","volume":"8","author":"Inaguma","year":"2017","journal-title":"Oncotarget"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1267359","DOI":"10.3389\/fvets.2023.1267359","article-title":"Chemosensitivity of three patient-derived primary cultures of canine pericardial mesothelioma by single-agent and combination treatment","volume":"10","author":"Nabeta","year":"2023","journal-title":"Front Vet Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1292\/jvms.19-0694","article-title":"Comparison of pancreatic and renal blood flow in a canine tachycardia-induced cardiomyopathy model","volume":"82","author":"Yoshimura","year":"2020","journal-title":"J Vet Med Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e85935","DOI":"10.1371\/journal.pone.0085935","article-title":"MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma","volume":"9","author":"Melaiu","year":"2014","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.mrfmmm.2014.11.002","article-title":"Expression status of candidate genes in mesothelioma tissues and cell lines","volume":"771","author":"Melaiu","year":"2015","journal-title":"Mutat Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-2105-7-85","article-title":"Statistical analysis of real-time PCR data","volume":"7","author":"Yuan","year":"2006","journal-title":"BMC Bioinform"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1158\/1055-9965.EPI-05-0334","article-title":"Mesothelin variant 1 is released from tumor cells as a diagnostic marker","volume":"15","author":"Hellstrom","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref22","volume-title":"Chapter 10 Glycophospholipid anchors. Essentials of Glycobiology","author":"Varki","year":"1999"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"16399","DOI":"10.1074\/jbc.M112.350009","article-title":"Efficient glycosylphosphatidylinositol (GPI) modification of membrane proteins requires a C-terminal anchoring signal of marginal hydrophobicity","volume":"287","author":"Galian","year":"2012","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ijc.2910500308","article-title":"Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium","volume":"50","author":"Chang","year":"1992","journal-title":"Int J Cancer"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3892\/br.2014.407","article-title":"Mechanism of alternative splicing and its regulation [review]","volume":"3","author":"Wang","year":"2015","journal-title":"Biomed Rep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"12127","DOI":"10.1016\/S0021-9258(18)98867-8","article-title":"Arg-X-Lys\/Arg\u2013Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway","volume":"266","author":"Hosaka","year":"1991","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13046-016-0314-2","article-title":"Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer","volume":"35","author":"Zervos","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1074\/jbc.M806776200","article-title":"A binding domain on mesothelin for CA125\/MUC16","volume":"284","author":"Kaneko","year":"2009","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1128\/MCB.20.8.2902-2906.2000","article-title":"Mesothelin is not required for normal mouse development or reproduction","volume":"20","author":"Bera","year":"2000","journal-title":"Mol Cell Biol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11912-023-01367-8","article-title":"Targeting mesothelin in solid tumours: anti-mesothelin antibody and drug conjugates","volume":"25","author":"Chu","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.14740\/wjon1655","article-title":"Biology of mesothelin and clinical implications: a review of existing literature","volume":"14","author":"Hagerty","year":"2023","journal-title":"World J Oncol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1158\/1541-7786.MCR-08-0095","article-title":"Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3","volume":"6","author":"Bharadwaj","year":"2008","journal-title":"Mol Cancer Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12943-017-0633-8","article-title":"Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells","volume":"16","author":"He","year":"2017","journal-title":"Mol Cancer"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1158\/1078-0432.CCR-11-2614","article-title":"Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients","volume":"18","author":"Servais","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion","volume":"279","author":"Rump","year":"2004","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1476-4598-5-50","article-title":"Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors","volume":"5","author":"Gubbels","year":"2006","journal-title":"Mol Cancer"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.lungcan.2009.07.016","article-title":"Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: implications for cancer therapy","volume":"68","author":"Hassan","year":"2010","journal-title":"Lung Cancer"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e1108","DOI":"10.1634\/theoncologist.2018-0896","article-title":"Mesothelin expression is a predictive factor for peritoneal recurrence in curatively resected stage III gastric cancer","volume":"24","author":"Shin","year":"2019","journal-title":"Oncologist"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1158\/1541-7786.MCR-19-0688","article-title":"Mesothelin enhances tumor vascularity in newly forming pancreatic peritoneal metastases","volume":"18","author":"Avula","year":"2020","journal-title":"Mol Cancer Res"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1038\/srep01870","article-title":"Mesothelin binding to CA125\/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation","volume":"3","author":"Chen","year":"2013","journal-title":"Sci Rep"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0021-9258(17)42180-6","article-title":"A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor cell line HPC-Y5","volume":"269","author":"Yamaguchi","year":"1994","journal-title":"J Biol Chem"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"21984","DOI":"10.1074\/jbc.270.37.21984","article-title":"Molecular cloning and expression of megakaryocyte potentiating factor cDNA","volume":"270","author":"Kojima","year":"1995","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1158\/1078-0432.CCR-06-0472","article-title":"Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma","volume":"12","author":"Onda","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3892\/ijmm.2010.573","article-title":"Exon deletion in the MSLN gene encoding MPF\/mesothelin precursor protein during Laurasiatherian mammal evolution","volume":"27","author":"Kim","year":"2011","journal-title":"Int J Mol Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature21706","article-title":"The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors","volume":"544","author":"Lefran\u00e7ais","year":"2017","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e137377","DOI":"10.1172\/JCI137377","article-title":"Lung megakaryocytes are immune modulatory cells","volume":"131","author":"Pariser","year":"2021","journal-title":"J Clin Invest"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejca.2007.08.028","article-title":"Mesothelin targeted cancer immunotherapy","volume":"44","author":"Hassan","year":"2008","journal-title":"Eur J Cancer"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1158\/1535-7163.MCT-11-0454","article-title":"Mesothelin-targeted agents in clinical trials and in preclinical development","volume":"11","author":"Kelly","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.1002\/cncr.33145","article-title":"Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin","volume":"126","author":"Hassan","year":"2020","journal-title":"Cancer"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2217\/imt.16.4","article-title":"Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy","volume":"8","author":"O\u2019Hara","year":"2016","journal-title":"Immunotherapy"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3390\/cancers14061550","article-title":"Mesothelin: an immunotherapeutic target beyond solid tumors","volume":"14","author":"Faust","year":"2022","journal-title":"Cancers"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1056\/NEJMra1403503","article-title":"Pleural disease","volume":"378","author":"Feller-Kopman","year":"2018","journal-title":"N Engl J Med"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1183\/16000617.0019-2016","article-title":"Malignant pleural effusion: from bench to bedside","volume":"25","author":"Psallidas","year":"2016","journal-title":"Eur Respir Rev"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1046\/j.1440-1843.2002.00404.x","article-title":"Mesothelial cells: their structure, function and role in serosal repair","volume":"7","author":"Mutsaers","year":"2002","journal-title":"Respirology"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fmed.2018.00089","article-title":"Free-floating mesothelial cells in pleural fluid after lung surgery","volume":"5","author":"Kienzle","year":"2018","journal-title":"Front Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/cncy.22398","article-title":"Diagnostic mesothelioma biomarkers in effusion cytology","volume":"129","author":"Eccher","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2024.1436621\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T01:11:16Z","timestamp":1725844276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2024.1436621\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":57,"alternative-id":["10.3389\/fvets.2024.1436621"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2024.1436621","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"article-number":"1436621"}}